Pete Sessions bought CME Group Inc (NASDAQ: CME)
Pete Sessions (R-TX), a U.S. Representative, has disclosed 1 trade in CME Group Inc (CME) since 2018, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Pete Sessions bought $15,001 - $50,000 of CME Group Inc (NASDAQ: CME) on August 2, 2018. Since that trade, CME is up +120.31% against the S&P 500 up +191.02%, an outperformance of -70.71%.
Data updated
Pete Sessions's CME trades vs the price
CME is up +120.31% since Pete Sessions bought on August 2, 2018, versus +191.02% for the S&P 500.
Performance since this trade
All Pete Sessions CME trades
Pete Sessions & CME trading FAQ
Is it legal for Pete Sessions to trade CME Group Inc (CME) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CME Group Inc (CME), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Pete Sessions buy CME?
Pete Sessions disclosed a purchase of $15,001 - $50,000 of CME Group Inc (CME) on August 2, 2018, according to public STOCK Act filings.
How has CME performed since Pete Sessions's trade?
Since Pete Sessions bought CME on August 2, 2018, the stock is up +120.31%, versus +191.02% for the S&P 500 over the same period, an outperformance of -70.71%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CME trades?
Quantellect tracks every disclosed congressional trade in CME Group Inc (CME) on the CME Group Inc congressional trading page, which aggregates filings across all members of Congress.
Pete Sessions's CME tradesAll congressional filings for CME Group IncPete Sessions's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.